The University of Greenwich’s CIPER team used Sinterit LISA to 3D print personalized drug tablets directly from extruded powder—without the need for filaments. By leveraging open SLS parameters, they developed tablets with tailored release profiles and drug strengths, reducing waste and accelerating pharmaceutical R&D.